United Kingdom — Cornwall Partnership NHS Foundation Trust
Tracked across 2 events · 12 articles · First seen Sep 02, 2026 · Last active Sep 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
The PrevenTron phase III clinical trial, led by United Kingdom — Cornwall Partnership NHS Foundation Trust in the UK, will test whether the experimental Alzheimer's drug trontinemab, developed by Roche, can prevent dementia in healthy…
Impact: The trust is the lead site in Europe for the trial, enhancing its research reputation and potentially attracting funding and partnerships.
Sep 04, 2026 · 6 articles
Tech
Impact: Collaborating NHS trust, providing clinical perspective. Minor reputational benefit.
Sep 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United Kingdom — Cornwall Partnership NHS Foundation Trust live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard